These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 903059)

  • 1. [Effect of benzbromarone in 100mg and 50mg doses on healthy subjects].
    Matzkies F; Berg G
    Fortschr Med; 1977 Jul; 95(27):1745-7. PubMed ID: 903059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hyperuricemia using daily doses of 50 and 25mg of benzbromarone].
    Matzkies F; Berg G; Minzlaff R
    Fortschr Med; 1977 Jul; 95(27):1748-50. PubMed ID: 332605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum uric acid and uric acid elimination after benzbromarone therapy in patients with gout and hyperuricemia].
    Matzkies F; Neuwirth R; Berg G
    Fortschr Med; 1976 Sep; 94(26):1427-9. PubMed ID: 976920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of benzbromarone and its combination with hydrochlorothiazide on renal excretion of uric acid and electrolytes.
    Malý J; Schück O
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):443-5. PubMed ID: 2258255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS; Fox IH
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
    Schräpler P; Kleinschmidt A; Haese E
    Med Klin; 1978 Jun; 73(23):861-6. PubMed ID: 661730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May; 97(17):835-6. PubMed ID: 437646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hyperuricemia and gout. Effect of a combination therapy of allopurinol with benzbromarone].
    Matzkies F
    Fortschr Med; 1983 May; 101(20):953-9. PubMed ID: 6873850
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP
    Med Klin; 1977 Apr; 72(15):664-8. PubMed ID: 857138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia].
    Matzkies F
    Med Klin (Munich); 1992 Sep; 87(9):460-2. PubMed ID: 1406482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of uric acid concentration in serum and saliva of healthy or hyperuricemic subjects].
    Schermann JM; Meunier J; Ricordel I; Masbernard A; Giudicelli C
    Ann Biol Clin (Paris); 1977; 35(6):467-72. PubMed ID: 615505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
    Bach D; Hesse A; Strenge A; Vahlensieck W
    Fortschr Med; 1980 Nov; 98(44):1752-5. PubMed ID: 7461567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of benzbromarone and its combination with hydrochlorothiazide on the renal excretion of uric acid and electrolytes].
    Malý J
    Cas Lek Cesk; 1986 Aug; 125(34):1053-6. PubMed ID: 3756994
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR; Dreykluft HR; Leonhardt H
    Fortschr Med; 1979 Jul; 97(27):1212-4. PubMed ID: 457017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP
    MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Variations in fecal elimination of uric acid in 8 patients treated with benzbromarone].
    Dupuich Y; Chandelier C; Niquet G
    LARC Med; 1983 Mar; 3(3):189-90. PubMed ID: 6865603
    [No Abstract]   [Full Text] [Related]  

  • 20. [Normurat (benzbromaron) in the treatment of gout].
    Bosmanský K; Trnavský K
    Z Rheumatol; 1979; 38(9-10):342-8. PubMed ID: 525067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.